-Search query
-Search result
Showing 1 - 50 of 561 items for (author: lian & ly)
EMDB-38873:
cryo-EM structure of Staphylococcus aureus(ATCC 29213) 50S ribosome in complex with MCX-190.
Method: single particle / : Li Y, Lu G, Li J, Pei X, Lin J
EMDB-38874:
Cryo-EM structure of Staphylococcus aureus (15B196) 50S ribosome in complex with MCX-190.
Method: single particle / : Li Y, Lu G, Li J, Pei X, Lin J
EMDB-38875:
Cryo-EM structure of Staphylococcus aureus 70S ribosome (strain 15B196) in complex with MCX-190.
Method: single particle / : Li Y, Lu G, Li J, Pei X, Lin J
EMDB-38876:
cryo-EM structure of Staphylococcus aureus(ATCC 29213) 70S ribosome in complex with MCX-190.
Method: single particle / : Li Y, Lu G, Li J, Pei X, Lin J
EMDB-44351:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, V1
Method: single particle / : Coupland EM, Rubinstein JL
EMDB-44350:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, Vo
Method: single particle / : Coupland CE, Rubinstein JL
EMDB-44352:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3, peripheral stalks
Method: single particle / : Coupland CE, Rubinstein JL
EMDB-44353:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 3
Method: single particle / : Coupland CE, Rubinstein JL
EMDB-44354:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 2
Method: single particle / : Coupland CE, Rubinstein JL
EMDB-44355:
Synaptic Vesicle V-ATPase with synaptophysin and SidK, State 1
Method: single particle / : Coupland CE, Rubinstein JL
EMDB-38216:
Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with antibody O5C2
Method: single particle / : Hsu HF, Wu MH, Chang YC, Hsu STD
EMDB-42676:
5-HT2AR bound to Lisuride in complex with a mini-Gq protein and an active-state stabilizing single-chain variable fragment (scFv16) obtained by cryo-electron microscopy (cryoEM)
Method: single particle / : Barros-Alvarez X, Kim K, Panova O, Roth BL, Skiniotis G
EMDB-42999:
5HT2AR-miniGq heterotrimer in complex with a novel agonist obtained from large scale docking
Method: single particle / : Gumpper RH, Wang L, Kapolka N, Skiniotis G, Roth BL
PDB-8uwl:
5-HT2AR bound to Lisuride in complex with a mini-Gq protein and an active-state stabilizing single-chain variable fragment (scFv16) obtained by cryo-electron microscopy (cryoEM)
Method: single particle / : Barros-Alvarez X, Kim K, Panova O, Roth BL, Skiniotis G
PDB-8v6u:
5HT2AR-miniGq heterotrimer in complex with a novel agonist obtained from large scale docking
Method: single particle / : Gumpper RH, Wang L, Kapolka N, Skiniotis G, Roth BL
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
PDB-8sx3:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
Method: single particle / : Huang J, Ozorowski G, Ward AB
EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
Method: single particle / : Karlinsey D, Ozorowski G, Ward AB
EMDB-41514:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41515:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41516:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41517:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41518:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41519:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 2-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41520:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41521:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 1-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41522:
Polyclonal immune complex of fab binding the H2 HA from serum of subject 1-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41541:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41543:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41544:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 3-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41545:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41546:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41547:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41548:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-1 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41549:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41550:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41551:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41552:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-2 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41553:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41554:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41555:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41556:
Polyclonal immune complex of Fab binding the H2 HA from serum of subject 4-3 at week 20
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41557:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 0
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41558:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 4
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41559:
Polyclonal immune complex of Fab binding the H1 HA from serum of subject 1-1 at week 16
Method: single particle / : Yang YR, Han J, Richey ST, Ward AB
EMDB-41639:
Langya henipavirus fusion protein in postfusion state
Method: single particle / : Wang Z, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
Pages: